Hepion Pharmaceuticals, Inc.
เพิ่มขึ้น

Extremely undervalued

ที่อัปเดต:
Overreaction to their public offering. Their cash balance would already be higher than their market cap once the offering is closed.
บันทึกช่วยจำ
Have closed the position for other trades
Chart PatternsFundamental AnalysisValue

คำจำกัดสิทธิ์ความรับผิดชอบ